Page last updated: 2024-12-05

2-phenylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Phenylglycine is an amino acid derivative that is a key precursor to various pharmaceuticals and fine chemicals. It is synthesized through various routes, including the Strecker synthesis and the Bucherer-Bergs reaction. The compound is known for its diverse applications, such as in the production of the anticonvulsant drug phenytoin, the antiviral drug valaciclovir, and several other pharmaceuticals. Its importance stems from its unique structural features that allow it to interact with various biological targets. Research into 2-phenylglycine focuses on developing new and efficient synthetic routes, exploring its potential as a building block for various therapeutic agents, and investigating its role in biological processes.'

2-phenylglycine: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

alpha-phenylglycine : An amino acid with a structure in which a phenyl ring is bonded to the alpha-carbon of glycine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3866
CHEMBL ID131226
CHEBI ID55484
SCHEMBL ID157180
MeSH IDM0053064

Synonyms (126)

Synonym
benzeneacetic acid, .alpha.-amino-
.alpha.-phenylglycine
nsc-7928
.alpha.-aminobenzeneacetic acid
.alpha.-aminophenylacetic acid
2-phenylglycine
69-91-0
nsc7928
.alpha.-toluic acid, .alpha.-amino-
glycine, 2-phenyl-
2-amino-2-phenylacetic acid
(.+/-.)-.alpha.-phenylglycine
benzeneacetic acid, .alpha.-amino-, (.+/-.)-
(.+-.)-.alpha.-phenylglycine
nsc-32070
2835-06-5
nsc24619
dl-phenylglycine
dl-.alpha.-aminophenylacetic acid
nsc32070
nsc-24619
glycine, dl-
dl-.alpha.-phenylglycine
dl-2-phenylglycine
2-amino-2-phenyl-acetic acid
alpha-phenylglycine
benzeneacetic acid, (s)-
l-(+)-.alpha.-aminophenylacetic acid
nsc-206293
l-.alpha.-phenylglycine
nsc206293
2-phenylglycine, 95%
amino(phenyl)acetic acid
STK182581
93378EBE-2D42-40BB-8CFB-2C976D8C188C
alpha-aminobenzeneacetic acid
dl-alpha-phenylglycine
alpha-aminophenylacetic acid
CHEBI:55484 ,
amino-phenyl-acetic acid
alpha-amino-alpha-toluic acid
CHEMBL131226
cas 69-91-0
(+/-)-alpha-aminophenylacetic acid
P0326
h-dl-phg-oh
AKOS000121220
BBL016492
A22760
(r)-phenylglycine;(r)-(-)-alpha-aminophenylacetic acid;(r)-alpha-aminophenylacetic acid
nsc 7928
einecs 200-719-1
einecs 220-608-1
nsc 32070
96s7zz1khe ,
nsc 24619
unii-96s7zz1khe
alpha-phenylgycine
alpha-toluic acid, alpha-amino-
benzeneacetic acid, alpha-amino-
dl-a-phenylglycine
(+/-)-a-aminophenylacetic acid
nsc 206293
dl-alpha-aminophenylacetic acid
FT-0673773
FT-0625602
FT-0625506
FT-0627997
FT-0624342
AM20060590
AB02597
AB00920
.alpha.-phenylglycine [mi]
phenylglycine, dl-
benzeneacetic acid, .alpha.-amino-, (.alpha.s)-
benzeneacetic acid, .alpha.-amino-, (s)-
2-amino-2-phenylethanoic acid
(+/-)-.alpha.-phenylglycine
c-phenylglycine
AKOS016042338
SCHEMBL157180
aminophenylacetic acid
(rs)-2-phenylglycine
amino(phenyl)acetic acid-, (s)-
W-107055
mfcd00064403
mfcd00064402
mfcd00008061
dl-phenyl-d5-glycine
J-521654
F2191-0177
rac-2-amino-2-phenylacetic acid
dl-alpha-phenylglycine, purum, >=98.0% (nt)
SR-01000944793-1
sr-01000944793
amino(phenyl)acetate
dl-a-aminophenylacetic acid
alpha-aminophenylacetate
dl-alpha-phenylaminoacetate
alpha-amino-benzeneacetic acid
2-amino-2-phenylacetate
dl-alpha-aminophenylacetate
alpha-aminobenzeneacetate
(+/-)-alpha-phenylglycine
dl-a-aminophenylacetate
2-phenyl-glycine
alpha-amino-benzeneacetate
(+/-)-a-phenylglycine
SY006358
SY005672
DTXSID70862455
dl-|a-phenylglycine
DS-13892
dl-2-phenyl-glycine
alpha-amino-alpha-toluate
dl-alpha-phenylaminoacetic acid
Q15633805
EN300-22835
CS-W010964
cephalexin impurity a;d-(-)-alpha-phenylglycine;h-d-phg-oh
BCP30023
D70539
HY-W010248
SY006196
phenylglycine dl
Z147647142

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor VIIa inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway."( Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors.
Ackermann, J; Alig, L; Banner, DW; Böhm, HJ; Hilpert, K; Kühne, H; Lavé, T; Obst-Sander, U; Riederer, MA; Stahl, M; Tschopp, TB; Weber, L; Wessel, HP; Zbinden, KG, 2005
)
0.33
" The oral bioavailability of D-phenylglycine-L-dopa was 31."( Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.
Fan, YB; Lu, HH; Tsai, MC; Tsai, TH; Wang, CL; Wang, HP, 2010
)
0.36
" The higher jejunal permeability and the improved systemic bioavailability of D-phenylglycine-L-dopa in comparison to that of l-dopa suggested that D-phenylglycine is an effective delivery tool for improving the oral absorption of drugs like L-dopa with unsatisfactory pharmacokinetics."( Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.
Fan, YB; Lu, HH; Tsai, MC; Tsai, TH; Wang, CL; Wang, HP, 2010
)
0.36

Dosage Studied

ExcerptRelevanceReference
"The striatal concentration of dopamine (DA), norepinephrine (NE), and homovanillic acid (HVA) was assessed in adult male rabbits exposed to styrene vapours or dosed with mandelic acid (MA), phenylglyoxylic acid (PGA) and phenylglycine (PG)."( Styrene metabolism and striatal dopamine depletion in rabbits.
Falzoi, M; Franchini, I; Lucertini, S; Mutti, A; Romanelli, A, 1985
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID191940Percent Stimulation of pyruvate oxidation in Rat by the compound was measured at 2 mM concentration of DCA (dichloroacetic acid)1981Journal of medicinal chemistry, Apr, Volume: 24, Issue:4
Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids.
AID394498Inhibition of Escherichia coli recombinant DNA gyrase-mediated supercoiling of relaxed pRSET A-DNA by agarose gel electrophoresis2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening.
AID188646Pyruvate dehydrogenase active/ Pyruvate dehydrogenase total was measured by sc administering the compound in rat at a dose of 1.2 mmol/kg1981Journal of medicinal chemistry, Apr, Volume: 24, Issue:4
Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids.
AID191932Tested for pyruvate oxidation in rat diaphragm, measured as % conversion of [14C]pyruvate to 14CO2 at 5 mM concentration1981Journal of medicinal chemistry, Apr, Volume: 24, Issue:4
Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids.
AID188648Pyruvate dehydrogenase activity in vivo was measured following subcutaneous administration of 1.2 mmol/kg1981Journal of medicinal chemistry, Apr, Volume: 24, Issue:4
Promotion of carbohydrate oxidation in the heart by some phenylglyoxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (77)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (9.09)18.7374
1990's10 (12.99)18.2507
2000's25 (32.47)29.6817
2010's29 (37.66)24.3611
2020's6 (7.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.08 (24.57)
Research Supply Index4.39 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]